Phase
Condition
N/ATreatment
AChE inhibitor monotherapy
AChE inhibitor and NMDA receptor antagonist combination therapy
Clinical Study ID
Ages > 65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
newly diagnosed with mild or moderate dementia using the Montreal CognitiveAssessment and Clinical Dementia Rating (CDR) performed by a licensedpsychometrician
clinically diagnosed by an expert adult neurologist as having probable AD using theNational Institute of Neurological and Communicative Disorders and Stroke andAlzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria
treatment naive for any acetylcholinesterase inhibitors or memantine OR those whohave not taken any acetylcholinesterase inhibitors or memantine in the last threemonths for any reasons except for adverse drug reaction
age 65 years old
residing in the National Capital Region
able to read and understand written and spoken English and Filipino
Exclusion
Exclusion Criteria:
with structural or vascular causes of dementia other than subcortical lacunes (2 orless) as seen in plain CT scan
dementia diagnosis other than AD as determined by an expert adult neurologist
with untreated depression or related psychiatric disorders in the last 6 months
use of systemic antibotics in the previous three months prior to providing fecalspecimens
use of corticosteroids, immune stimulating medications, and immunosuppressive agentswithin the past 2 weeks or those who regularly need them for immune-relateddisorders
use of proton-pump inhibitors, H2-receptor antagonists, H2-receptor antagonists,tricyclic antidepressants, narcotics, anticholinergic medications, laxatives oranti-diarrheal in the past 4 weeks
large doses of commercial probiotics consumed (greater than or equal to 108 cfu ororganisms per day)
major dietary change during previous month (defined as eliminating or significantlyincreasing a major food group)
major GI tract surgery in the past 5 years, with the exception of cholecystectomyand appendectomy
major bowel resection at any time
active uncontrolled GI disorders or diseases, including inflammatory bowel disease,indeterminate colitis, irritable bowel syndrome, persistent infectiousgastroenteritis, colitis or gastritis, persistent or chronic diarrhea of unknownetiology, recurrent Clostridium difficile infection, untreated Helicobacter pyloriinfection, chronic constipation
Study Design
Study Description
Connect with a study center
Philippine General Hospital
Manila, Metro Manila 1000
PhilippinesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.